宏柏新材(605366.SH):擬終止實施“功能性氣凝膠生產基地建設項目”
格隆匯12月13日丨宏柏新材(605366.SH)公佈,公司擬終止實施公司首次公開發行募集資金投資項目中尚未實施完畢的“功能性氣凝膠生產基地建設項目”(以下簡稱“該項目”),並將該項目剩餘募集資金永久補充流動資金,用於公司日常生產經營及業務發展。
截至2024年11月30日,“功能性氣凝膠生產基地建設項目”已累計投入募集資金6,979.37萬元,並建成功能性氣凝膠一期項目,產能為3000立方;剩餘募集資金2,943.31萬元。該項目終止後,剩餘募集資金本金2,256.88萬元及利息686.43萬元,共計2,943.31萬元(具體金額以實際結轉時項目專户資金餘額為準)將用於永久性補充公司流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.